Regencell Bioscience Holdings Limited (RGC)
Largest Insider Buys in Sector
RGC Stock Price History Chart
RGC Stock Performance
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Insider Activity of Regencell Bioscience Holdings Limited
Over the last 12 months, insiders at Regencell Bioscience Holdings Limited have bought $0 and sold $0 worth of Regencell Bioscience Holdings Limited stock.
On average, over the past 5 years, insiders at Regencell Bioscience Holdings Limited have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $369,000 was made by BELL THOMAS D JR (director) on 2017‑08‑29.
List of Insider Buy and Sell Transactions, Regencell Bioscience Holdings Limited
| 2017-08-29 | director | 25,000 0.4487% | $14.76 | $369,000 | ||||
| 2017-08-25 | director | 10,000 0.1808% | $14.87 | $148,700 | ||||
| 2017-08-24 | EVP, CFO and Treasurer | 7,500 0.128% | $14.04 | $105,300 | ||||
| 2017-03-09 | Sale | EVP, General Counsel, Sec. | 20,233 0.5535% | $22.50 | $455,243 | |||
| 2017-03-09 | Sale | President and COO | 26,050 0.7016% | $22.15 | $577,008 | |||
| 2016-11-23 | Sale | 10 percent owner | 13M – | $22.95 | $298.35M | |||
| 2016-09-07 | Sale | President and COO | 30,765 0.8136% | $21.75 | $669,139 | |||
| 2016-08-08 | Sale | 10 percent owner | 13M – | $21.60 | $280.8M | |||
| 2016-06-29 | Sale | EVP, General Counsel, Sec. | 49,024 1.2822% | $21.51 | $1.05M | |||
| 2016-06-15 | Sale | President and COO | 25,000 0.6165% | $20.28 | $507,000 | |||
| 2016-03-15 | Sale | CEO | 28,201 0.7139% | $20.82 | $587,145 | |||
| 2016-03-14 | Sale | CEO | 75,000 1.9352% | $21.22 | $1.59M | |||
| 2015-05-19 | Sale | President and COO | 19,000 0.4944% | $21.40 | $406,600 | |||
| 2015-03-13 | director | 88.14 0.0024% | $22.54 | $1,987 | ||||
| 2015-02-18 | Sale | director | 58,475 1.6616% | $23.37 | $1.37M | |||
| 2014-06-05 | Sale | President and COO | 25,000 0.6107% | $20.09 | $502,250 | |||
| 2011-02-28 | Sale | President and COO | 90,000 1.6415% | $15.00 | $1.35M | |||
| 2010-07-12 | Sale | 10 percent owner | 7.3M – | $13.70 | $100M | |||
| 2010-07-12 | 10 percent owner | 7.3M – | $13.70 | $100M | ||||
| 2009-11-23 | director | 2,000 0.0332% | $13.64 | $27,280 |